pharma Β· Myotonic Dystrophy Type 1 Β· Myotonic Dystrophy Type 1 (DM1) Β· DYN
Dyne Therapeutics
Dyne Therapeutics trial registry β 6 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- Waltham, USA
- Founded
- 2018
- Employees
- 276
- Programs
- 6
- Drugs
- 11
- Patents
- 82
Dyne Therapeutics clinical trials
Registry index of 6 ClinicalTrials.gov studies linked to Dyne Therapeutics programs β each row shows trial ID, program name, phase, status, and indication.
Dyne Therapeutics trial registry β 6 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Dyne Therapeutics.
-
DYNE-101 for Myotonic Dystrophy Type 1 β Phase 2
Clinical update -
DYNE251-DMD-201 β Phase 2
Clinical update -
SODIUM CHLORIDE , DYNE-101 β Phase 3
Clinical update -
zeleciment basivarsen (DYNE-101) β Phase 3
Clinical update -
DYNE-251 β Phase 2
Clinical update -
DYNE-101 β Phase 2
Clinical update
Trial registry
-
CTIS β -
CTIS β -
CTIS β -
CT.gov β -
CT.gov β -
CT.gov β